ELFABRIO
NDC 10122-165, pegunigalsidase alfa, injection, solution, concentrate, from Chiesi USA, Inc..
- Product NDC
- 10122-165
- Status
- Listed
- Labeler
- Chiesi USA, Inc.
- Dosage form
- INJECTION, SOLUTION, CONCENTRATE
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761161
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10122-165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PEGUNIGALSIDASE ALFA5 mg/2.5mL
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10122-165-02 | 10122016502 | 1 VIAL, SINGLE-DOSE in 1 CARTON (10122-165-02) / 2.5 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/6fb674bf-744e-431f-92ef-b2a5a66c8cf3Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=10122-165
Use it
Look up 10122-165 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10122-165 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10122-165. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.